Funding Rounds
Reapplix Series A (2020, $22M)
ReapplixTechnology that identifies blood-derived proteins to enhance wound healing for patients with chronic wounds.
Summary
Stage: Series A
Raised Amount: $22.60M
Raised Date: 2020-01-01
Stage: Series A
Raised Amount: $22.60M
Raised Date: 2020-01-01